AHA Letter to HHS Secretary Becerra on 340B Eligibility

March 31, 2021

AHA urges the Department of Health and Human Services (HHS) to ensure hospitals currently participating in the 340B Drug Pricing Program continue to have access to the program despite changes in their payer mix as a result of the COVID-19 public health emergency (PHE).

We specifically request a waiver of certain 340B program eligibility criteria for 340B hospitals enrolled during the PHE that may have experienced a temporary change in payer mix due to the COVID-19 pandemic.

View the entire letter under Key Resources. 

Related Resources

Special Bulletin
Public
Download the AHA Special Bulletin: CMS Issues Hospital Outpatient/ASC Proposed Rule, Including Modifications to Price Transparency Rule
Advancing Health Podcast
Public
Columbus, Ohio-based Mount Carmel Health System goes beyond the walls of its hospital to serve its community and patients through programs such as Street…
Letter/Comment
Public
Amy Bricker President Express Scripts PBM 1 Express Way Saint Louis, MO 63121 Dear Ms. Bricker:
Action Alert
Member
Please contact your members of Congress and urge them to support legislation that will provide certainty to hospitals participating in the 340B Drug Pricing…
Letter/Comment
Public
The AHA expresses support for legislation  H.R. 3203 introduced in the House that would provide certainty to hospitals participating in the 340B Drug Pricing…
Letter/Comment
The AHA and five other health care organizations sent the attached letter to HHS Secretary Becerra urging him to stop the actions of six drug companies that…